Excess Morbidity Persists in Patients With Cushing's Disease During Long-term Remission: A Swedish Nationwide Study
- 1 August 2020
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 105 (8), 2616-2624
- https://doi.org/10.1210/clinem/dgaa291
Abstract
Context: Whether multisystem morbidity in Cushing's disease (CD) remains elevated during long-term remission is still undetermined. Objective: To investigate comorbidities in patients with CD. Design, Setting, and Patients: A retrospective, nationwide study of patients with CD identified in the Swedish National Patient Register between 1987 and 2013. Individual medical records were reviewed to verify diagnosis and remission status. Main Outcomes: Standardized incidence ratios (SIRs) with 95% confidence intervals (Os) were calculated by using the Swedish general population as reference. Comorbidities were investigated during three different time periods: (i) during the 3 years before diagnosis, (ii) from diagnosis to 1 year after remission, and (iii) during long-term remission. Results: We included 502 patients with confirmed CD, of whom 419 were in remission for a median of 10 (interquartile range 4 to 21) years. SIRs (95% CI) for myocardial infarction (4.4; 1.2 to 11.4), fractures (4.9; 2.7 to 8.3), and deep vein thrombosis (13.8; 3.8 to 35.3) were increased during the 3-year period before diagnosis. From diagnosis until 1 year after remission, SIRs (95% CI were increased for thromboembolism (18.3; 7.9 to 36.0), stroke (4.9; 1.3 to 12.5), and sepsis (13.6; 3.7 to 34.8). SIRs for thromboembolism (4.9; 2.6 to 8.4), stroke (3.1; 1.8 to 4.9), and sepsis (6.0; 3.1 to 10.6) remained increased during long-term remission. Conclusion: Patients with CD have an increased incidence of stroke, thromboembolism, and sepsis even after remission, emphasizing the importance of early identification and management of risk factors for these comorbidities during long-term follow-up.Funding Information
- ALF-agreement (ALFGBG-593301)
- Gothenburg Society of Medicine
This publication has 39 references indexed in Scilit:
- Glucocorticoid‐induced osteoporosis: lessons from Cushing's syndromeClinical Endocrinology, 2013
- Hypercoagulability in Cushing's syndrome: prevalence, pathogenesis and treatmentClinical Endocrinology, 2013
- Mortality and morbidity in Cushing’s syndrome in New ZealandClinical Endocrinology, 2011
- External review and validation of the Swedish national inpatient registerBMC Public Health, 2011
- Cardiac dysfunction is reversed upon successful treatment of Cushing's syndromeActa Endocrinologica, 2010
- The completeness of the Swedish Cancer Register – a sample survey for year 1998Acta Oncologica, 2009
- Hypercortisolemia and InfectionInfectious Disease Clinics of North America, 2007
- Bone Demineralization and Vertebral Fractures in Endogenous Cortisol Excess: Role of Disease Etiology and Gonadal StatusJournal of Clinical Endocrinology & Metabolism, 2006
- Cushing’s Syndrome Due to Ectopic Corticotropin Secretion: Twenty Years’ Experience at the National Institutes of HealthJournal of Clinical Endocrinology & Metabolism, 2005
- Osteoporosis Associated with Excess GlucocorticoidsEndocrinology and Metabolism Clinics of North America, 2005